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TM4SF5Transmembrane 4 L six family member 5 (TM4SF5) enhances cell migration and invasion, although how
TM4SF5 mechanistically mediates these effects remains unknown. In the study, during efforts to understand
TM4SF5-mediated signal transduction, TM4SF5 was shown to bind c-Src and thus hepatoma cell lines ex-
pressing TM4SF5 were analyzed for the signiﬁcance of the interaction in cell invasion. The C-terminus of
TM4SF5 bound both inactive c-Src that might be sequestered to certain cellular areas and active c-Src that
might form invasive protrusions. Wildtype (WT) TM4SF5 expression enhanced migration and invasive pro-
trusion formation in a c-Src-dependent manner, compared with TM4SF5-null control hepatoma cell lines.
However, tailless TM4SF5ΔC cells were more efﬁcient thanWT TM4SF5 cells, suggesting a negative regulatory
role by the C-terminus. TM4SF5 WT- or TM4SF5ΔC-mediated formation of invasive protrusions was depen-
dent or independent on serum or epidermal growth factor treatment, respectively, although they both
were dependent on c-Src. The c-Src activity of TM4SF5WT- or TM4SF5ΔC-expressing cells correlated with en-
hanced Tyr845 phosphorylation of epidermal growth factor receptor. Y845F EGFR mutation abolished the
TM4SF5-mediated invasive protrusions, but not c-Src phosphorylation. Our ﬁndings demonstrate that
TM4SF5 modulates c-Src activity during TM4SF5-mediated invasion through a TM4SF5/c-Src/EGFR signaling
pathway, differentially along the leading protrusive edges of an invasive cancer cell.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Cancer metastasis is dynamically regulated by coordinated signal-
ing pathways that respond to the extracellular matrix (ECM) or solu-
ble factors [1]. Cell migration involves new focal adhesions or contacts
in the leading edges, adhesion-dependent regulation of RhoA GTPase
activity, intracellular contractility, actin reorganization, and disassem-
bly of focal adhesions in rear edges [1]. Invasion involves degradation
of the ECM via formation of invasive morphological features depending
on cell adhesion signaling activity [2].
Cell adhesion causes tyrosine phosphorylations and activations of di-
versemolecules at focal adhesions (FAs, [3]). Among these FAmolecules,
focal adhesion kinase (FAK) is autophosphorylated at Tyr397when cellsyn-, and Yes-negative mouse
YF cells; SFKs, c-Src family
M4SF5, Transmembrane 4 L6
M4SF5
ul National University, Seoul
2 1795.
rights reserved.adhere. Phosphorylated Tyr397 recruits Src-homology 2 (SH2)-domain
containing molecules like c-Src, which phosphorylates other Tyr resi-
dues in FAK [4]. The FAK–c-Src complex is thus involved importantly
in modulating diverse signaling pathways after cells adhere [5]. c-Src is
a well-known tyrosine kinase involved in cell adhesion and/or growth
factor receptor (GFR)-mediated signal transduction. c-Src Tyr416
phosphorylation by the FAK-Src complex upon cell adhesion results
in its activation, whereas Tyr527 phosphorylation by Src tyrosine ki-
nase (Csk) leads to inactivation [6]. During activation of epidermal
growth factor receptor (EGFR), tyrosines 992, 1068, 1086, 1148,
and 1173 are autophosphorylated after epidermal growth factor (EGF)
interaction [7]. Cell adhesion-activated c-Src can also phosphorylate
EGFR in a different pattern for tyrosines 845, 891, 920, and 1101 even
without EGF binding [8].
Invasive morphological features including invadopodia and invasive
protrusions sense the ECM around the leading edges of a cell and in-
volve adhesion-dependent signaling activities [9]. Such invasive fea-
tures involve dynamic actin remodeling: c-Src-mediated cortactin
phosphorylation causes activation of Arp2/3, consequently leading to
actin branching and polymerization at lamellipodia and invasive pro-
trusions [10].
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are suggested to locate at the tetraspanin-enriched microdomains
(TERMs) of the cell membrane [11] and collaborate with integrins for
cell adhesion and migration [12]. Transmembrane 4 L six family mem-
ber 5 (TM4SF5) is a membrane glycoprotein with four transmembrane
domains, and its intracellular loop and N- and C-terminal tails are locat-
ed in the cytosol [13]. TM4SF5 is highly expressed in diverse clinical
cancer tissues, and its overexpression causes aberrant proliferation, an-
giogenesis, migration, and invasion [14]. However, it is unknown how
TM4SF5mechanistically mediates its tumorigenic effects and which in-
tracellular signaling pathways are emanated from TM4SF5. During
studies on TM4SF5-mediated signaling, we found c-Src as a physical
binder of the C-terminal tail of TM4SF5, which became the pivotal
data of this study.
We hypothesized that TM4SF5 might regulate c-Src for cell inva-
sion and thus examined how TM4SF5 could regulate c-Src activity
and invasive features. We found that the C-terminus of TM4SF5
interacted with both active and inactive c-Src. Wildtype (WT) or
C-terminus-deleted TM4SF5ΔC resulted in activation of c-Src and en-
hanced formation of invasive protrusions. Furthermore, these
TM4SF5-mediated effects depended on Tyr845 phosphorylation of
EGFR. TM4SF5, c-Src suppression, or Y845F EGFR mutation abolished
the invasive protrusions formation, indicating a regulatory signal link
from TM4SF5/c-Src complex to EGFR during cell invasion.
2. Materials and methods
2.1. Cell culture
Control (SNU449, SNU761 parental, and SNU761-mock), TM4SF5WT
(SNU449-TM4SF5 and SNU761-TM4SF5 WT), or mutant (SNU761-
TM4SF5 ΔICL13,ΔICL19, or TM4SF5ΔC)-expressing human hepatocellular
carcinoma cellswere described previously [15] or prepared byG418 (A.G.
Scientiﬁcs, Waltham, MA, USA) selection following transfection of
FLAG-mock, -TM4SF5WT, -TM4SF5 ΔICL13, TM4SF5 ΔICL19, or TM4SF5-
ΔC plasmids into TM4SF5-null SNU449 or SNU761 hepatoma cell lines.
Stable cells were maintained in RPMI-1640 (WelGene, Daegu, Korea)
containing 10% FBS, G418 (250 μg/ml) and antibiotics (Invitrogen,
Carlsbad, CA, USA). Endogenously TM4SF5-null SNU398, SNU449, and
SNU761 or TM4SF5-expressing SNU368, HepG2, and Huh7 hepatoma
cell lines were maintained in DMEM-H or RPMI-1640 (WelGene)
containing 10% FBS and antibiotics (Invitrogen). SYF (c-Src, Yes, and
Fyn-negative) and SYF++ (SYF reconstituted with c-Src) cells that en-
dogenously express TM4SF5were kindly gifted by Dr. Lee Graves (Dept.
of Pharmacology, Univ. of North Carolina at Chapel Hill, NC, USA).
2.2. Peptides, cDNAs, siRNA, and shRNA
Peptides 1MCTGKCARCV10 (N-terminally cytosolic), 69RAGGKGC
CGAGCCGNRCRMLRSV91 (intracellular loop, ICL), or 187GDCRKKQD
TPH197 (C-terminally cytosolic) were commercially synthesized to con-
tainN-terminally-linked biotinwithoutmodiﬁcations and then puriﬁed
(90%, Peptron Inc.). The TM4SF5 cDNA sequence (NM-003963, 197 aa)
was conjugated to the FLAG tag, and deletion mutations in the intracel-
lular loop or C-terminus were generated to produce 69RA–90SV (ΔICL19
with a deletion of 71GGKGCCGAGCCGNRCRMLR89), 69RAGGK–87MLRSV
(ΔICL13 with a deletion of 74GCCGAGCCGNRCR86), or C-terminal tail
(187GDCRKKQDTPH197)-deleted (ΔC) TM4SF5. GST-TM4SF5, myc-
(His)6-TM4SF5, FLAG-TM4SF5, FLAG-TM4SF5 ΔICL13, FLAG-TM4SF5
ΔICL19, or FLAG-TM4SF5ΔC, and Y845F EGFR constructs were
engineered and conﬁrmed by direct sequence analyses. GST-c-Src
WT, -SH3, -SH2, or -SH2SH3 constructs were also previously de-
scribed [16], and pKH3-(HA)3-c-SrcWT, K295R, Y416F, or Y527Fmu-
tants were previously explained [17]. siRNA against c-Src was
previously explained [18]. shRNAs against TM4SF5 or controlsequence are previously explained, and control shRNA was designed
for a scrambled sequence [15].
2.3. Extract preparation and Western blots
Subconﬂuent cells in media containing 10% FBS or cells transiently
transfected with the indicated plasmids for 48 h were harvested for
whole cell lysates. Cells were transiently transfected with shRNA
against control scrambled sequence or TM4SF5 (shTM4SF5) or pFLAG
(Mock), pEGFP (GFP), Myc-(His)6-TM4SF5 (MH-TM4SF5), FLAG-
TM4SF5 WT, intracellular loop deleted (ΔICL13 or ΔICL19), C-terminal
deleted (ΔC) TM4SF5 mutant, pKH6-(HA)3-c-Src WT, inactive c-Src
Y416F, constitutively active c-Src Y527F, kinase-dead c-Src K295R mu-
tant plasmids for 48 h, prior to harvests or replating as previously
explained [19]. The cells were harvested using a lysis buffer containing
1% Brij58, 150 mM NaCl, 20 mM HEPES, pH 7.4, 2 mM MgCl2, 2 mM
CaCl2, and protease inhibitors. Primary antibodies used include
anti-pY397FAK (Abcam, Cambridge, UK), pY577FAK (Invitorgen),
pY416Src, pY527Src, pY845EGFR, pY992EGFR (Cell Signaling Technol.
Danvers, MA, USA), pY486Cortactin (Millipore, Bellerica, MA, USA),
α-tubulin, FLAG, talin, (Sigma, St Louis, MO, USA), pY118paxillin, c-Src,
pY1173EGFR, (His)6, HA, pY925FAK (Santa Cruz Biotech., Santa Cruz, CA,
USA), GST, paxillin, FAK (BD Transduct. Lab., Bedford, MA, USA), or
TM4SF5 [homemade [15]]. The density ratio was evaluated by image
J determination.
2.4. Cell surface protein analysis
Localization of TM4SF5 WT and FLAG-TM4SF5ΔC mutant on plasma
membranes was analyzed using Pierce® Cell Surface Isolation Kit
(Pierce, Rockford, IL), as previously explained [20]. Subconﬂuent cells
biotinylated for 30 min at 4°C with ensuring even coverage of the
cells with the labeling solution of the kit were harvested for preparation
of biotinylated surface protein samples, prior to immunoblotting
against the indicated molecules. Coimmunoprecipitation between
FLAG-TM4SF5 WT or -TM4SF5ΔC mutant and other proteins using
membrane fractions were also performed. The membrane fraction
was prepared by ProteoExtract® Subcellular Proteome Extraction
Calbiochem® kit following the manufacturer's protocols. Brieﬂy,
subconﬂuent cells in 10 mm tissue culture dishes were twice washed
with the Wash buffer of the kit with a gentle rocking for 5 min at 4°C.
The cells were covered with Extraction buffer I with protease inhibitor
cocktail for 10 min at 4°C with gentle rocking. After removal of the su-
pernatant, the remaining cellularmaterials were incubatedwith Extrac-
tion buffer II with protease inhibitor cocktail for 30 min at 4°C with
gentle rocking. The supernatant was transferred to a new tube for pro-
tein determination and immunoblotting or immunoprecipitation using
anti-FLAG antibody (Sigma).
2.3. In vitro pull down
In vitro pull down using biotin-conjugated peptides of the cytosol-
ic TM4SF5 regions or recombinant GST-fused c-Src proteins and cell
extracts was performed using streptavidin agarose beads (Millipore),
as previously described [19]. The biotin–peptides (1 μM) was incu-
bated with SNU449 parental cell extracts (500 μg proteins) or recom-
binant GST alone, GST–c-Src WT, or -c-Src fragments overnight, prior
to precipitation with streptavidin-agarose and standard Western
blots.
2.4. Coimmunoprecipitation
Whole cell extracts were prepared using the lysis buffer from
TM4SF5-null SNU449 or SNU761 parental hepatoma cells expressing
Myc-(His)6-mock, Myc-(His)6-TM4SF5, FLAG-mock, FLAG-TM4SF5,
pKH3-(HA)3-c-Src WT, pKH3-(HA)3-c-Src Y416F, pKH3-(HA)3-c-Src
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tion for 48 h. Thewhole cell lysates ormembrane fractions as explained
above were immunoprecipitated with anti-FLAG antibody-precoated
agarose beads (Sigma), c-Src, or -EGFR antibody overnight, prior to im-
munoblotting for the indicated molecules. Alternatively, cell extracts
were incubated with anti-(His)6 antibody overnight prior to protein
A/G bead precipitation at 4°C for 2 h.Washed immunoprecipitated pro-
teins were processed to standard Western blots.
2.5. Indirect immunoﬂuorescence
Cells were transiently transfected with FLAG-TM4SF5 WT or
TM4SF5ΔC mutant for 48 h, prior to a double-staining using antibody
against phospho-Y527c-Src and FLAG, or phospho-Y845EGFR and
FLAG.
2.6. Transwell migration or invasion assay
SNU449 or SNU761 cells stably or SYF or SYF++mouse embryonic
ﬁbroblasts cells transiently transfected with FLAG (mock), FLAG-
TM4SF5WT or -TM4SF5ΔCmutantwere analyzed formigration or inva-
sion, as explained previously [21]. The migration assay was performed
for migration toward 10% FBS separately for 12, 16, or 24 h. The inva-
sion throughmatrigelwas done for 36 h using a transwell chamber sys-
tem,whose bottom chamber side contained culturemediawith 10% FBS
in the absence or presence of 100 ng/ml EGF (PeproTech, Rocky Hill, NJ,
USA).
2.7. Invasive protrusion analysis
Cells without or with transient transfection of FLAG (mock),
FLAG-TM4SF5 or mCherry-TM4SF5 WT, or FLAG-TM4SF5ΔC or
mCherry-TM4SF5ΔC mutant were analyzed for invasive protrusions by
culturing cells on Oregon Green® 488-conjugated gelatin (Invitrogen),
prior to seeing the black spots following degradation of gelatin. Invasive
protrusions of cells onOregonGreen®488-conjugated-gelatinwere an-
alyzed as described in a previous report [21].
2.8. Statistical methods
Student's t-tests were performed for comparisons of mean values
to determine signiﬁcance. p valuesb0.05 were considered signiﬁcant.
3. Results
3.1. The C-terminal tail of TM4SF5 bound and regulated c-Src family
kinases (SFKs)
To study TM4SF5-mediated intracellular signaling, the intracellular
regions of TM4SF5 were analyzed for binding to cell adhesion-related
molecules using a peptide pull-down approach. Peptides of the cytosolic
N- and C-terminal domains, or the intracellular loop (ICL) were sepa-
rately mixed with whole cell extracts of SNU449 hepatoma cells. Inter-
estingly, FAK and talin bound the ICL of TM4SF5 (Fig. 1A, and [20]), but
SFK (i.e., Src family kinases because the c-Src antibody recognized the
members of c-Src, fyn, and yes) bound the C-terminal tail (Fig. 1A). Ad-
ditionally, ectopic Myc-(His)6-TM4SF5 co-immunoprecipitated with
c-Src, whereas control normal IgG did not (Fig. 1B). The binding be-
tween TM4SF5 and SFKs in suspended cells was slightly stronger than
that in adherent cells (Fig. 1C). SFKs still bound to the ICL deletion mu-
tants of TM4SF5 (ΔICL13 or ΔICL19 whose 13 or 19 amino acids of 23
amino acid ICL were deleted, respectively), whereas FAK did not bind
TM4SF5ΔICL19 (Fig. 1D). As expected, based on the observation that
the C-terminal tail of TM4SF5 does not include tyrosine residues or
proline-enriched domains, in vitro pull down using GST-c-Src WT or
fragments and TM4SF5 peptides showed that GST-c-Src WT boundonly the C-terminal peptide, but other GST-c-Src SH2, SH3, or SH2SH3
fragments did not (Fig. 1E). These data indicate that c-Src interacts
with the C-terminal tail of TM4SF5 via regions other than its SH2SH3
domain.
Because suspended cells showed an interaction between TM4SF5
and SFKs, we examined whether the phosphorylation status of c-Src
might affect its binding with TM4SF5. TM4SF5-null SNU761 cells
were transiently cotransfected with Myc-(His)6-TM4SF5 and either
the (HA)3-c-Src WT, Y416F, or Y527F mutant, before immunoprecip-
itation with (His)6 antibody followed by Western blotting for the
(HA)3 tag. Interestingly, inactive Y416F c-Src more effectively bound
to TM4SF5, compared with WT or active Y527F c-Src (Fig. 1F). Addi-
tionally, kinase-dead K295R c-Src bound TM4SF5 comparably to inac-
tive Y416F c-Src (Fig. 1G).
To reveal the biological signiﬁcance of the interaction, we generated
C-terminus-deleted TM4SF5 (TM4SF5ΔC) and checked signaling activi-
ties after stable transfection of mock, WT, or TM4SF5ΔC. Although WT
TM4SF5 expression increased Tyr416 c-Src phosphorylation (i.e.,
pY416c-Src), pY397FAK, pY577FAK, and pY486cortactin, TM4SF5ΔC ex-
pression further increased their phosphorylations, compared with
mock or WT expression (Fig. 2A). Additionally, both TM4SF5 WT and
TM4SF5ΔC decreased the inhibitory phosphorylation on Tyr527 of
c-Src (i.e., pY527c-Src, Fig. 2A). Furthermore, TM4SF5ΔC transfection
greatly enhanced pY486cortactin regardless of whether inactive Y416F
or active Y527F c-Src constructs were cotransfected presumably be-
cause of over-activated endogenous c-Src. However, Y527F c-Src
cotransfection was required for a signiﬁcant cortactin phosphorylation
when TM4SF5 WT was transfected (Fig. 2B). When localizations of
TM4SF5 and Tyr527-phosphorylated (i.e., inactive) c-Src were deter-
mined by immunostaining, pY527c-Src inWT TM4SF5 cells was positive
at certain areas of lamellipodia but not completely along the leading
edges (63±4.7%), and pY527c-Src in TM4SF5ΔC cells was hardly ob-
served along the leading edges (87±6.2%, Fig. 2C). These observations
may indicate that the interaction between TM4SF5 and either inactive
or active c-Src leads to regulation of c-Src activity, presumably by limit-
ing the location of inactive c-Src at certain leading edge areas during cell
migration and invasion.3.2. Tailless TM4SF5ΔC enhanced migration and invasion
We next examined whether mock, TM4SF5 WT, and TM4SF5ΔC
cells differentially migrate or invade by using the transwell assay.
TM4SF5 WT- and TM4SF5ΔC-transfected SNU449 hepatoma cells
were efﬁciently migrated toward 10% fetal bovine serum (FBS) in
the bottom chamber in a time-dependent manner compared with
mock cells, although TM4SF5ΔC cells migrated to a greater degree
than TM4SF5 WT cells (Fig. 2D). However, the cells did not show sig-
niﬁcant migration toward bovine serum albumin (Fig. 2D, graph).
Similarly, stable TM4SF5 WT and TM4SF5ΔC SNU761 hepatoma cell
lines also invaded efﬁciently through Matrigel toward 10% FBS in
the bottom chamber, compared with control mock cells (Fig. 2E).
We next examined whether the enhanced migration of TM4SF5
WT and TM4SF5ΔC hepatoma cells depended on c-Src. Using SYF ﬁ-
broblasts (lacking c-Src, Fyn, and Yes) and SYF cells reconstituted
with c-Src (SYF++, Fig. 2F) that express endogenous TM4SF5, we an-
alyzed migration after transient transfection of mock, TM4SF5 WT, or
TM4SF5ΔC. TM4SF5 WT- and TM4SF5ΔC-transfected SYF cells mini-
mally migrated without any time-dependent increases, whereas
TM4SF5 WT- and TM4SF5ΔC-transfected SYF++ cells dramatically
increased migration toward 10% FBS compared with mock cells
(Fig. 2G). Interestingly, TM4SF5ΔC-transfected SYF++ cells migrated
more than did TM4SF5 WT-transfected SYF++ cells (Fig. 2G), being
consistent with TM4SF5ΔC-transfected SYF++ cells showing higher
pY416c-Src than TM4SF5 WT-transfected SYF++ cells (Fig. 2F).
These observations indicate that the C-terminal tail of TM4SF5 can
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Fig. 1. The C-terminal tail of TM4SF5 bound SFK and regulated c-Src activity. (A) In vitro pull down using peptides of TM4SF5 cytosolic regions shows binding between the intra-
cellular parts of TM4SF5, c-Src, and talin. N-ter, the NH2-terminal tail of TM4SF5; Intra loop, the intracellular loop of TM4SF5; C-ter tail, C-terminal tail. (B) Extracts from
myc-(His)6-TM4SF5 (MH-TM4SF5)-transfected SNU449 cells were immunoprecipitated with either normal rabbit IgG (Nor. IgG) or anti-(His)6 rabbit polyclonal antibody, prior
toWestern blots for c-Src or (His)6-tag. (C) Cell extracts prepared from suspended (Sus) or replated on ﬁbronectin (FN) for 2 h were immunoprecipitated with anti-(His)6 antibody,
prior to immunoblotting for c-Src. (D) SNU761 cells stably transfected with FLAG-TM4SF5 WT, ΔICL13, or ΔICL19 mutant were immunoprecipitated with FLAG antibody-precoated
agarose beads, prior to immunoblottings for FAK, c-Src, or FLAG tag. (E) In vitro peptide pull down was performed by using peptides for the cytosolic regions of TM4SF5 and recom-
binant proteins of GST alone, GST-c-Src WT, SH3 domain, SH2 domain, and SH2SH3 domain, prior to immunoblotting for GST tag. (F and G) SNU761 cells were transiently
cotransfected with Myc-(His)6-TM4SF5 and either pKH6-(HA)3-c-Src WT, Y416F, Y527F (F), or K295R mutant (G) for 48 h, prior to harvests of whole cell extracts. The extracts
were immunoprecipitated with anti-(His)6 antibody and then immunoblotted for anti-(HA)3 antibody. The band intensities among experimental conditions determined by
image J are shown as relative values (G). Data represent three independent experiments.
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gration and invasion.
3.3. TM4SF5 modulated invasive protrusions
Tounderstand howTM4SF5mediates invasion,we analyzedwhether
and how TM4SF5 might control invasive features such as invasiveprotrusions with activities to degrade the ECM. ECM degradation was
visualized via microscopic observation of dark spots after the gelatin
underneath cells was degraded by culturing cells on ﬂuorophore-
conjugated gelatin [2]. We ﬁrst examined invasive protrusions between
endogenously or exogenously TM4SF5-expressing and TM4SF5-null
or -suppressed cells. SNU398, SNU449, and SNU761 hepatoma cell
lines did not express TM4SF5, whereas SNU368, Huh7, and HepG2
633O. Jung et al. / Biochimica et Biophysica Acta 1833 (2013) 629–642hepatoma cell lines expressed TM4SF5 (Fig. 3A). When SNU398 and
SNU368 cells were examined, TM4SF5-positive SNU368 cells formed in-
vasive protrusions where ﬂuorophore-conjugated gelatin was degraded
to become dark spots, whereas TM4SF5-null SNU398 cells did not
(Fig. 3B and E). Ectopic overexpression of TM4SF5 in SNU449 and
SNU761 cells enhanced invasive protrusion formations, compared with
mock transfected cells (Fig. 3C and E). Furthermore, suppression of en-
dogenous TM4SF5 from Huh7 and HepG2 cells using sort hairpin RNA
(shRNA) against TM4SF5 (shTM4SF5) did not form invasive protrusions,
whereas a control shRNA against a scrambled sequence did (Fig. 3D
and E). Compared with control mock cells, stable SNU761-TM4SF5 WTpY5FLAG
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Fig. 2 (continued).
634 O. Jung et al. / Biochimica et Biophysica Acta 1833 (2013) 629–642c-Src from stable SNU761 cells using its siRNA efﬁciently inhibited inva-
sive protrusion formation (Fig. 4A and B). Such c-Src-dependent inva-
sive protrusion formation in stable TM4SF5 WT or TM4SF5ΔC cells
were also conﬁrmed using SYF or SYF++ ﬁbroblasts. Although SYF
cells transfected with either mock, TM4SF5 WT, or TM4SF5ΔC did not
form invasive protrusions, SYF++ cells transfected with TM4SF5 WT
or TM4SF5ΔC, but not with mock, efﬁciently formed invasive protru-
sions: TM4SF5ΔC-transfected SYF++ cells were more efﬁcient to form
the protrusions than TM4SF5 WT-transfected cells (Figs. 4C and S2).
These results suggest that TM4SF5 WT and TM4SF5ΔC cells require
c-Src to form invasive protrusions.Because we found that TM4SF5 mediated formation of invasive
protrusions (Fig. 3) and TM4SF5 bound inactive c-Src, we speculated
that the phosphorylation status of c-Src either at Tyr416 or Tyr527 af-
fected invasive protrusion formation. To test this ﬁnding, SYF or
SYF++ cells were transiently transfected with either Y416F or
Y527F c-Src or cotransfected with both Y416F and Y527F c-Src (at a
mole ratio of 1:1) before analysis of invasive protrusion formation. In-
terestingly, SYF cells transfected with any of the c-Src constructs did
not efﬁciently form invasive protrusions (Figs. 4D and S3). However,
SYF++ cells transfected with the constructs could signiﬁcantly
form the invasive protrusions. Cotransfection of both Y416F and
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635O. Jung et al. / Biochimica et Biophysica Acta 1833 (2013) 629–642Y527F c-Src showed greater formation of invasive protrusions than
single transfection of either inactive Y416F or active Y527F c-Src
(Fig. 4D). Interestingly, expression of inactive Y416F c-Src in
SYF++ cells resulted in a slightly greater formation of invasive pro-
trusions compared with active Y527F expression in SYF++ cells
(Fig. 4D), although it is unclear how and why it occurred, or if the
difference might not be biologically meaningful. These results strong-
ly suggest that WT c-Src is required for TM4SF5-mediated formation
of invasive protrusions, in addition to Tyr-(un)phosphorylated
c-Src. When the c-Src constructs were transiently transfected into
SNU761-mock or SNU761-TM4SF5 cells (with endogenous c-Src),
single transfection of Y416F or Y527F c-Src and cotransfection of
Y416F and Y527F c-Src caused efﬁcient formation of invasive protru-
sions, being more dramatically enhanced in SNU761-TM4SF5 cells
than in SNU761-mock cells (Figs. 4E and S4). Active Y527F c-Srctransfection formed the protrusions approximately 50% more than
did Y416F c-Src transfection, whereas cotransfection of Y416F and
Y527F c-Src resulted in an intermediate level of invasive protrusion
formation (Fig. 4E), although why the pattern between the c-Src
constructs is different from that of SYF/SYF++ cell systems cannot
currently be explained.
3.5. TM4SF5 WT formed invasive protrusions depending on growth
factors, whereas TM4SF5ΔC did independently
When signaling activities were examined in stable SNU761 cells,
we interestingly found that EGFR phosphorylation in TM4SF5 WT or
TM4SF5ΔC cells was slightly or much higher, respectively, than in con-
trol mock cells (Fig. 5A, left 3 lanes). Because TM4SF5-mediated for-
mation of invasive protrusions may involve EGFR phosphorylation,
636 O. Jung et al. / Biochimica et Biophysica Acta 1833 (2013) 629–642we next checked the effects of serum deprivation on c-Src and EGFR
phosphorylation. Compared with mock cells, TM4SF5WT or TM4SF5ΔC
cells showed higher pY416c-Src and pY845EGFR, pY992EGFR, andA
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637O. Jung et al. / Biochimica et Biophysica Acta 1833 (2013) 629–642less serum dependency compared with mock cells (Fig. 5A). This case
was also valid when the cells were treated with or without EGF:
TM4SF5 WT cells showed increased pY416c-Src, pY845EGFR, andpY992EGFR in an EGF-dependent manner, whereas TM4SF5ΔC cells
showed the increases independent of EGF (Fig. 5B). Because pY416c-Src
and pY845EGFR in TM4SF5 WT cells depended on serum or EGF,
638 O. Jung et al. / Biochimica et Biophysica Acta 1833 (2013) 629–642pY845EGFR appeared more relevant to c-Src activity, which may be re-
sponsible for the invasive protrusion formation difference between
TM4SF5 WT and TM4SF5ΔC cells.
To distinguish the difference in dependency of TM4SF5 WT and
TM4SF5ΔC cells on serum or EGF treatment, we analyzed invasion
throughMatrigel and formation of invasive protrusions under an exper-
imental condition including 10% FBS±EGF. In the presence of 10% FBS
alone, TM4SF5 WT and TM4SF5ΔC cells showed enhanced invasion
through the Matrigel, compared with mock cells (Figs. 5C and S5). Ad-
ditional EGF treatment increased invasion of mock and TM4SF5 WT
cells but not that of TM4SF5ΔC cells (Figs. 5C and S5). That is, TM4SF5ΔC
cells showed an invasion capacity independent of additional EGF treat-
ment. Thiswas also valid for invasive protrusion formation.Whenmock
cells did not show formation of invasive protrusions with or without
EGF treatment, TM4SF5 WT and TM4SF5ΔC cells showed efﬁcient
formation of invasive protrusions. TM4SF5 WT cells showed anM
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3.6. TM4SF5-mediated invasive protrusions required c-Src and Tyr845
phosphorylation of EGFR
Because TM4SF5 WT and TM4SF5ΔC cells showed increased
pY416c-Src, pY845EGFR, and invasive protrusion formation, we won-
dered how these effects were interconnected. We thus analyzed sig-
naling activities of stable SNU761 cells transfected with control or
c-Src siRNA. Suppression of c-Src abolished almost completely
pY416c-Src and pY845EGFR, slightly pY992EGFR, but not pY1173EGFR
in the cells (Fig. 6A). Thus TM4SF5-mediated invasive protrusion for-
mation may likely involve c-Src-dependent EGFR Tyr845 phosphory-
lation. To test this ﬁnding, we transiently transfected Y845F EGFR into
the stable SNU761 cells, prior to analysis of invasive protrusions.OG488-gelatin45F EGFR Actin
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639O. Jung et al. / Biochimica et Biophysica Acta 1833 (2013) 629–642Although mock cells did not form invasive protrusions in either
Y845F EGFR-transfected or -untransfected cells, TM4SF5 WT and
TM4SF5ΔC cells formed signiﬁcant invasive protrusions only when
Y845F EGFR was not transfected (Fig. 6B, arrow and C). WhenTM
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640 O. Jung et al. / Biochimica et Biophysica Acta 1833 (2013) 629–642of invasive protrusions via an increase in Tyr845 phosphorylation of
EGFR.3.7. TM4SF5-mediated invasive protrusions via the TM4SF5/c-Src/EGFR
pathway
The relationship among TM4SF5, c-Src, and EGFR was further
investigated. Stable SNU761-TM4SF5 or -TM4SF5ΔC cells transfected
with Y845F EGFR were analyzed for colocalization between TM4SF5
and pY845EGFR. Interestingly, TM4SF5 WT-expressing cells showed
colocalization of TM4SF5 and pY845EGFR around lamellipodia, whereas
they were separately localized in TM4SF5ΔC cells (Fig. 7A). The interac-
tion between TM4SF5 WT, but not TM4SF5ΔC, and pY845EGFR was also
conﬁrmed by coimmunoprecipitation (Fig. 7B). When either EGFR WT
or the Y845F mutant was transiently transfected into stable SNU761
cells, SNU761-mock cells did not show a detectable interaction between
c-Src and EGFR, whereas SNU761-TM4SF5 or -TM4SF5ΔC cells showed
an obvious interaction between c-Src and EGFR WT, although
SNU761-TM4SF5ΔC cells showed a greater interaction. The interaction
was obvious when EGFR WT was transfected, but it was much reduced
when Y845F EGFR was transfected (Fig. 7C). Additionally, SNU761-
TM4SF5WT cells transfected with EGFRWT showed an interaction be-
tween FLAG-TM4SF5 and EGFR, but a minimal interaction between
FLAG-TM4SF5 and pY416c-Src, although SNU761-mock and TM4SF5ΔC
cells did not show interaction between FLAG-TM4SF5 and pY416c-Src
(Fig. 7C). Furthermore, Y845F EGFR transfection to FLAG-TM4SF5 WT
cells reversed the coimmunoprecipitation pattern: interaction between
FLAG-TM4SF5 and EGFR was markedly inhibited, whereas interaction
between FLAG-TM4SF5 and pY416c-Src was substantially increased
after Y845F EGFR transfection (Fig. 7C). Thus, pY416c-Src may likely
more tightly bind to EGFR when Tyr845 can be phosphorylated, but to
TM4SF5 when Tyr845 cannot be phosphorylated. Consistently, EGFR
immunoprecipitates only from SNU761-TM4SF5ΔC cells, but not from
SNU761-TM4SF5 WT cells, pulled down pY416c-Src when EGFR WT
was transfected, whereas the interaction between EGFR and pY416c-Src
was reduced in Y845F EGFR-transfected SNU761-TM4SF5ΔC cells
(Fig. 7D), indicating that (enhanced) pY845EGFR is important for recruit
of pY416c-Src in SNU761-TM4SF5ΔC cells. The isolated plasma
membrane fraction showed similar levels of TM4SF5 WT and
TM4SF5ΔC, indicating that the C-terminal deletion might not impairFig. 8. Working model for TM4SF5-mediated regulationits trafﬁcking to the plasma membrane (Fig. 7E). Immunoprecipita-
tion of FLAG-TM4SF5 in the membrane fractions from SNU761
cells expressing mock, FLAG-TM4SF5 WT, or -TM4SF5ΔC mutant
co-precipitated pY845EGFR and pY416c-Src in SNU761-TM4SF5 WT
cells but not SNU761-TM4SF5ΔC cells (Fig. 7F). These colocalization
and coimmunoprecipitation data support that TM4SF5 WT interacts
with either pY527c-Src (to limit inactive c-Src to certain areas
where TM4SF5 localizes; Fig. 8, left) or pY416c-Src to link signaling
to pY845EGFR for TM4SF5-mediated cortactin activation and invasive
protrusion formation (Fig. 8, middle). The C-terminal tail of TM4SF5
may likely regulate c-Src activity; thus, in TM4SF5ΔC cells, c-Src is
somehow (see Discussion) activated and recruited to pY845EGFR
for more efﬁcient invasive protrusion formation (Figs. 8, right and
up, and 6). However, when pY845EGFR is not available, active c-Src
bound mostly to TM4SF5 but not to EGFR; no signal linkage from
TM4SF5 to EGFR might lead presumably to less effective invasion
(Figs. 8, right and down, and 6).4. Discussion
The present study demonstrates that the C-terminal tail of TM4SF5
binds and regulates c-Src, which is required for EGFR phosphorylation
at Tyr845 and formation of invasive protrusions for an enhanced inva-
sion. Because TM4SF5 is highly expressed in hepatocarcinoma and
plays roles in aberrant cell proliferation and enhanced metastatic
potential [14], understanding of TM4SF5-mediated intracellular signal
pathways would be important for development of therapeutic reagents
against tumorigenesis mediated by TM4SF5 or -related signaling mole-
cule(s). The present study suggests that the C-terminus-mediated regu-
lation of c-Src (family kinase) activity can be targeted to inhibit invasion
of TM4SF5-positive tumors, such as hepatocellular carcinoma.
The C-terminal tail of TM4SF5 consists of 11 amino acids without a
speciﬁc protein subdomain. In the current study, we found that the
C-terminal tail of TM4SF5 interacted with SFK via regions other than
the SH2SH3 domain in c-Src. The C-terminus of TM4SF5 bound more
efﬁciently to inactive or kinase-dead c-Src than active or Y416-
phosphorylated c-Src, although active c-Src could still bind TM4SF5.
The interaction between TM4SF5 and SFKs was more efﬁcient in
suspended cells (where c-Src would be generally inactive) than in
adherent cells. The preferred binding between the C-terminus ofof c-Src activity and invasive protrusion formation.
641O. Jung et al. / Biochimica et Biophysica Acta 1833 (2013) 629–642TM4SF5 and inactive c-Src was unexpected, because we previously
found that the ICL of TM4SF5 bound FAK to activate the actin-
polymerizing machinery at the leading edges during a directional
migration [20], and FAK/c-Src complex is well-known to control cell
migration [22].
The interaction between the C-terminus of TM4SF5 and inactive
SFKs may result in sequestration of inactive c-Src within certain loca-
tions during cell migration and invasion. The inactive (i.e., pY527c-Src)
c-Src was located in certain peripheries of leading edges. At the loca-
tions of leading edges, inactive SFKs may limit activation of cortactin,
a component of the actin-polymerizing machinery [10]. TM4SF5
could also bind active c-Src at leading edges with active formation
of invasive protrusions. Active FAK is also recruited at the leading
edges via binding to the ICL of TM4SF5 and forms a complex with
molecules involved in the actin-polymerizing/branching machinery
[20]. Therefore, even along the leading periphery of a migratory cell,
there are possible regions with different capacities for actin polymer-
ization and branching to direct dynamic cellular protrusions toward a
speciﬁc direction.
TM4SF5 is amember of the tetraspan(in) family [13] that localizes to
a speciﬁc membrane domain, the tetraspanin enriched microdomain
(TERM or TEM) [11]. At the TERM, tetraspan(in)s form complexes
with other tetraspan(in)s, integrins, or growth factor receptors [23].
Such massive complexes may transduce signals for diverse biochemical
processes such as local actin polymerization and branching. Via physical
interactions with other membrane receptors, tetraspan(in)-like
TM4SF5 can regulate membrane activities to form local protrusions or
retractions, presumably depending on differential microenvironments
near the membrane [14]. Consistently, the membrane fraction from
TM4SF5 WT-expressing cells showed complex formation among
TM4SF5, (pY845)EGFR, and (pY416)c-Src, whereas themembrane frac-
tion from tailless TM4SF5ΔC cells did not show complex formation be-
tween tailless TM4SF5ΔC and (pY845)EGFR (Fig. 7F). pY845EGFR and
invasive protrusion formation in TM4SF5WT cells were further depen-
dent on serum or EGF treatment. However, tailless TM4SF5ΔC cells
were independent of serum or EGF treatment and showed c-Src
overactivation. We observed that active c-Src bound to a complex be-
tween TM4SF5 and EGFR WT (Fig. 7C and D). Active c-Src minimally
bound to TM4SF5 WT when EGFR was phosphorylated at Tyr845, but
much more bound to TM4SF5 WT when EGFR was not phosphorylated
at Tyr845 (Fig. 7C). Thus, there must be at least two separate complex
groups along the leading edges: onemay consist of TM4SF5 and inactive
SFKs to limit protrusion formation and the other may contain TM4SF5,
active c-Src(/FAK), and pY845EGFR to promote invasive protrusions.
The observations in the current study may support a role for the
C-terminus of TM4SF5 in the regulation of SFKs. C-terminal deletion
of TM4SF5 activated SFKs greater than TM4SF5 WT (Figs. 2, 5, 6 and
7B), suggesting its negative regulatory role in SFK signaling. The
C-terminal peptide of TM4SF5 bound more efﬁciently to inactive
c-Src than active c-Src (Fig. 1), although its underlying mechanisms
remains unclear and its understanding may thus need details in struc-
tural aspects. We observed that more c-Src was found in the mem-
brane fraction of TM4SF5ΔC cells (i.e., active c-Src on membrane
[24], Fig. 7F), and inactive c-Src localized on certain membrane
areas (Fig. 2C). Therefore, removal of the C-terminus of TM4SF5
might result in a less recruitment of inactive c-Src to the leading
edges. It may be speculated that a certain population of TM4SF5
may sequester inactive c-Src around certain membrane areas rather
than leading edges, although investigation in detail on such a possi-
bility remains. c-Src activity in TM4SF5 or TM4SF5ΔC cells correlated
with pY845EGFR (Figs. 6 and 7), and c-Src suppression abolished
pY845EGFR (Fig. 6A). Furthermore, a stronger association between ac-
tive c-Src and pY845EGFR in TM4SF5ΔC cells than in TM4SF5 WT cells
was observed (Fig. 7C and D). pY845EGFR is a c-Src phosphorylation
site even without ligand binding [25]. Y845F EGFR transfection did
not alter c-Src activity but inhibited formation of invasive protrusionsof TM4SF5 WT and TM4SF5ΔC cells, suggesting a signaling link from
c-Src to EGFR for invasive protrusion formation. TM4SF5ΔC cells may
thus acquire c-Src activation even without growth factor stimulation
and result in more signal linkage for invasive protrusions.
SYF cells lacking SFKs or cells with c-Src suppression showed min-
imal pY845EGFR and invasive protrusions. Invasive protrusions in
TM4SF5 WT or TM4SF5ΔC cells required expression of c-Src WT in ad-
dition to active and/or inactive c-Src. It was previously reported that
active c-Src alone in head and neck squamous cell carcinoma results
in invadopodia formation but not signiﬁcant ECM degradation,
whereas WT c-Src (which may convert to inactive and/or active
c-Src form inside cells) caused efﬁcient invadopodia maturation and
ECM degradation [26]. Another previous study showed that v-Src
overexpression into MtLN3 breast cancer cells results in less ECM
degradation per invadopodia [27]. Active or inactive c-Src inside
cells, which may be converted from WT c-Src depending on signaling
contexts, may be differentially involved in complicate processes in-
cluding invadopodia maturation (via an action of active c-Src) and
ECM degradation (via invadopodia maturation by an action of WT
c-Src) [26]. Therefore, c-Src WT form, but not active or inactive
c-Src form only, led to efﬁcient ECM degradation. The difference in
c-Src requirement for the ECM degradation in hepatoma cell lines
(the present study) and MtLN3 cells may be due to differential
expression levels of molecule(s) involved in ECM-degradation via
formation of invasive protrusions or invadopodia, such as TM4SF5.
In conclusion, the present study demonstrated that the C-terminal
tail of TM4SF5 can regulate SFK activities via direct binding, which in
turn can lead to Tyr845 phosphorylation of EGFR during formation of
invasive protrusions along invasive peripheries and suggests that
TM4SF5 may be targeted to inhibit the invasion of TM4SF5-positive
tumors.
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